Attached files

file filename
EX-10.3 - Hemp Naturals, Inc.ex10_3.htm
EX-10.2 - Hemp Naturals, Inc.ex10_2.htm
EX-10.1 - Hemp Naturals, Inc.ex10_1.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K/A

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 27, 2018

HEMP NATURALS, INC.

(Exact name of Registrant as specified in its charter)

 

 

Delaware   000-55590   47-5604166

(State or other jurisdiction of

incorporation or organization)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

   

16950 North Bay Road, Suite 18033

Sunny Isles Beach, Florida

  33160
(Address of principal executive offices)   (Zip Code)

  

Registrant’s Telephone Number, including area code: (347) 301-8431

 

Not Applicable                

(Former name, former address and former fiscal year, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 1 

 

 

Explanatory Note

 

This Amendment to Form 8-K originally filed on December 28, 2018, is filed solely to correct clerical errors in Item 1.01 Entry into a Material Definitive Agreement. Paragraph 1 of item 1.01 stated the Company entered into entered into a securities purchase agreement with Adar Bays, LLC when in fact it should have stated the Company entered into a securities purchase agreement with GS CAPITAL PARTNERS, LLC. Other than correcting this error, all other information included in the Original Report is unchanged.

 

  

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

On December 19, 2018 (“Closing Date”), Hemp Naturals, Inc. (the “Company”) entered into a securities purchase agreement (the “Agreement”) with GS CAPITAL PARTNERS, LLC (the “Investor”), pursuant to which the Company will issue up to approximately $140,000 in two 8% Secured Convertible Promissory Notes, (“Notes”) with a face value of $70,000 each which provides conversion features equal to 55% of the lowest trading price of the Company’s common stock for the last 20 trading days prior to conversion, as well as 8% per annum interest. The Agreement includes customary representations, warranties and covenants by the Company and customary closing conditions.

 

On the Closing Date December 20, 2018, the Company reserved Two million three hundred fifty thousand (2,314,000) shares of its common stock, (“Common Stock”) for issuance upon for conversion of the Notes in accordance with the terms thereof (“Reserved Shares”). The Investor shall have the right to periodically request that the number of Reserved Shares be increased so that the number of Reserved Shares equals at least 700% of the number of shares of Company common stock issuable upon conversion of the Notes.

 

The foregoing descriptions of the Securities Purchase Agreement, and the Notes do not purport to be complete and are qualified in their entirety by reference to the full text of the transaction documents, copies of which are filed as Exhibits 10.1, 10.2, and 10.3 , respectively, to this Current Report on Form 8-K.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits:

 

Exhibit

No.

  Description
10.1   Securities Purchase Agreement
10.2   Convertible Promissory Note
10.3   Convertible Promissory Note (Back End Note)

  

 2 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

             
        HEMP NATURALS, INC.
       
Date: December 31, 2018       By:   /s/ Levi Jacobson
            Levi Jacobson
            Chief Executive Officer

 

 3